Concepts (228)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Toll-Like Receptors | 11 | 2024 | 93 | 4.330 |
Why?
|
| Adjuvants, Immunologic | 16 | 2024 | 169 | 4.270 |
Why?
|
| Immunity, Innate | 8 | 2024 | 434 | 2.900 |
Why?
|
| Polymers | 11 | 2021 | 196 | 2.850 |
Why?
|
| NF-kappa B | 6 | 2024 | 469 | 2.300 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 3 | 2024 | 23 | 1.990 |
Why?
|
| Inflammasomes | 3 | 2024 | 26 | 1.970 |
Why?
|
| Vaccines | 5 | 2023 | 84 | 1.800 |
Why?
|
| Dendritic Cells | 7 | 2023 | 451 | 1.640 |
Why?
|
| Dinitrochlorobenzene | 2 | 2022 | 3 | 1.480 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2024 | 91 | 1.360 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2020 | 35 | 1.250 |
Why?
|
| Lipopeptides | 2 | 2021 | 17 | 1.230 |
Why?
|
| Biomimetic Materials | 2 | 2021 | 24 | 1.180 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2021 | 125 | 1.170 |
Why?
|
| Small Molecule Libraries | 2 | 2024 | 65 | 1.120 |
Why?
|
| Light | 3 | 2017 | 292 | 1.070 |
Why?
|
| Antigen Presentation | 3 | 2022 | 215 | 0.990 |
Why?
|
| Cancer Vaccines | 2 | 2024 | 159 | 0.970 |
Why?
|
| Nanoparticles | 3 | 2023 | 165 | 0.950 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2024 | 30 | 0.930 |
Why?
|
| Interleukin-1beta | 1 | 2024 | 82 | 0.920 |
Why?
|
| Purines | 1 | 2024 | 93 | 0.910 |
Why?
|
| High-Throughput Screening Assays | 1 | 2024 | 58 | 0.900 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 600 | 0.880 |
Why?
|
| Macrophages | 4 | 2024 | 582 | 0.850 |
Why?
|
| Mice | 17 | 2024 | 11858 | 0.840 |
Why?
|
| Dermatitis, Contact | 1 | 2022 | 6 | 0.820 |
Why?
|
| Allergens | 2 | 2022 | 183 | 0.790 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 61 | 0.790 |
Why?
|
| Animals | 26 | 2024 | 27536 | 0.780 |
Why?
|
| Disulfides | 1 | 2021 | 65 | 0.740 |
Why?
|
| Mechanical Phenomena | 1 | 2021 | 15 | 0.740 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2021 | 31 | 0.730 |
Why?
|
| Ovalbumin | 1 | 2021 | 109 | 0.730 |
Why?
|
| Lignans | 1 | 2020 | 6 | 0.720 |
Why?
|
| Mutant Proteins | 1 | 2021 | 96 | 0.720 |
Why?
|
| Vibration | 1 | 2021 | 50 | 0.720 |
Why?
|
| Biphenyl Compounds | 1 | 2020 | 59 | 0.710 |
Why?
|
| Oligonucleotides | 1 | 2021 | 92 | 0.710 |
Why?
|
| Antigens | 1 | 2021 | 229 | 0.680 |
Why?
|
| Immunoassay | 1 | 2020 | 93 | 0.680 |
Why?
|
| Immunologic Factors | 2 | 2022 | 171 | 0.670 |
Why?
|
| Lactic Acid | 3 | 2014 | 93 | 0.640 |
Why?
|
| Lymphocytes | 1 | 2020 | 468 | 0.600 |
Why?
|
| Mice, Inbred C57BL | 7 | 2024 | 3253 | 0.590 |
Why?
|
| Molecular Structure | 7 | 2019 | 293 | 0.590 |
Why?
|
| Bacterial Vaccines | 3 | 2024 | 44 | 0.590 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2017 | 5 | 0.590 |
Why?
|
| Drug Discovery | 1 | 2018 | 107 | 0.580 |
Why?
|
| Hydrogels | 2 | 2008 | 87 | 0.580 |
Why?
|
| Optogenetics | 1 | 2016 | 37 | 0.540 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 136 | 0.530 |
Why?
|
| RAW 264.7 Cells | 3 | 2021 | 18 | 0.510 |
Why?
|
| Molecular Probes | 1 | 2015 | 35 | 0.490 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2014 | 5 | 0.470 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2014 | 8 | 0.470 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 754 | 0.470 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2013 | 24 | 0.450 |
Why?
|
| Microscopy, Atomic Force | 2 | 2024 | 53 | 0.450 |
Why?
|
| Teichoic Acids | 1 | 2013 | 18 | 0.440 |
Why?
|
| Models, Cardiovascular | 1 | 2013 | 107 | 0.430 |
Why?
|
| Colorimetry | 2 | 2012 | 8 | 0.420 |
Why?
|
| Polyesters | 5 | 2019 | 42 | 0.420 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 295 | 0.400 |
Why?
|
| Vaccines, Synthetic | 3 | 2022 | 56 | 0.390 |
Why?
|
| Gases | 1 | 2012 | 30 | 0.390 |
Why?
|
| Composite Resins | 1 | 2011 | 4 | 0.390 |
Why?
|
| Models, Molecular | 7 | 2018 | 1315 | 0.380 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 201 | 0.370 |
Why?
|
| Water | 2 | 2012 | 286 | 0.370 |
Why?
|
| Antifreeze Proteins | 1 | 2010 | 6 | 0.360 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2021 | 20 | 0.360 |
Why?
|
| Q Fever | 2 | 2021 | 8 | 0.360 |
Why?
|
| Coxiella burnetii | 2 | 2021 | 11 | 0.360 |
Why?
|
| Polymerization | 5 | 2021 | 33 | 0.350 |
Why?
|
| Inflammation | 1 | 2015 | 981 | 0.320 |
Why?
|
| Metallothionein | 1 | 2008 | 13 | 0.320 |
Why?
|
| Metals, Heavy | 1 | 2008 | 15 | 0.320 |
Why?
|
| Cell Line | 4 | 2019 | 2495 | 0.310 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 88 | 0.310 |
Why?
|
| Proteins | 3 | 2010 | 787 | 0.310 |
Why?
|
| T-Lymphocytes | 3 | 2024 | 1221 | 0.300 |
Why?
|
| Neoplasms | 1 | 2023 | 3067 | 0.290 |
Why?
|
| Materials Testing | 2 | 2021 | 93 | 0.280 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2021 | 700 | 0.280 |
Why?
|
| Vaccines, Subunit | 3 | 2021 | 55 | 0.270 |
Why?
|
| Chlamydia muridarum | 1 | 2024 | 3 | 0.240 |
Why?
|
| Mice, Inbred BALB C | 3 | 2022 | 1091 | 0.240 |
Why?
|
| Chlamydia Infections | 1 | 2024 | 31 | 0.240 |
Why?
|
| Administration, Intranasal | 1 | 2024 | 139 | 0.230 |
Why?
|
| Humans | 14 | 2024 | 90014 | 0.230 |
Why?
|
| Liposomes | 1 | 2024 | 93 | 0.230 |
Why?
|
| Aminopyridines | 1 | 2024 | 40 | 0.230 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2024 | 19 | 0.230 |
Why?
|
| Immunologic Memory | 1 | 2024 | 164 | 0.210 |
Why?
|
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2022 | 5 | 0.210 |
Why?
|
| Cells, Cultured | 2 | 2020 | 2887 | 0.200 |
Why?
|
| Temperature | 4 | 2021 | 409 | 0.200 |
Why?
|
| Immunity, Cellular | 1 | 2023 | 178 | 0.200 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2022 | 47 | 0.200 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 450 | 0.190 |
Why?
|
| Gels | 1 | 2021 | 49 | 0.190 |
Why?
|
| Vaccines, Conjugate | 1 | 2021 | 6 | 0.190 |
Why?
|
| Autoantigens | 1 | 2022 | 129 | 0.190 |
Why?
|
| Zinc Oxide | 1 | 2021 | 3 | 0.190 |
Why?
|
| Click Chemistry | 1 | 2021 | 5 | 0.190 |
Why?
|
| Cell-Free System | 1 | 2021 | 51 | 0.190 |
Why?
|
| Heat-Shock Proteins | 1 | 2022 | 183 | 0.190 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 150 | 0.180 |
Why?
|
| Sulfhydryl Compounds | 1 | 2021 | 71 | 0.180 |
Why?
|
| Lipid A | 1 | 2020 | 3 | 0.180 |
Why?
|
| Polystyrenes | 1 | 2020 | 7 | 0.180 |
Why?
|
| Antigen-Presenting Cells | 1 | 2021 | 142 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2024 | 586 | 0.170 |
Why?
|
| Nanostructures | 1 | 2021 | 79 | 0.170 |
Why?
|
| Models, Animal | 1 | 2021 | 277 | 0.170 |
Why?
|
| Immune Tolerance | 1 | 2022 | 341 | 0.170 |
Why?
|
| Ligands | 1 | 2021 | 447 | 0.170 |
Why?
|
| Carrier Proteins | 1 | 2023 | 679 | 0.160 |
Why?
|
| Immunotoxins | 1 | 2019 | 14 | 0.160 |
Why?
|
| Transfection | 1 | 2021 | 909 | 0.160 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2022 | 312 | 0.160 |
Why?
|
| Influenza, Human | 1 | 2022 | 340 | 0.160 |
Why?
|
| Oligopeptides | 1 | 2020 | 188 | 0.160 |
Why?
|
| HEK293 Cells | 1 | 2021 | 646 | 0.160 |
Why?
|
| Cell Adhesion | 1 | 2020 | 426 | 0.160 |
Why?
|
| Vaccination | 1 | 2021 | 279 | 0.160 |
Why?
|
| Immune System | 2 | 2023 | 97 | 0.160 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 95 | 0.160 |
Why?
|
| Kinetics | 1 | 2021 | 1534 | 0.150 |
Why?
|
| Lymph Nodes | 2 | 2023 | 550 | 0.150 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2017 | 2 | 0.150 |
Why?
|
| Acetals | 1 | 2017 | 3 | 0.150 |
Why?
|
| Amphotericin B | 1 | 2017 | 34 | 0.150 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 110 | 0.150 |
Why?
|
| Immunotherapy | 1 | 2023 | 699 | 0.140 |
Why?
|
| Adaptive Immunity | 2 | 2018 | 167 | 0.140 |
Why?
|
| Cytokines | 1 | 2021 | 811 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1929 | 0.140 |
Why?
|
| Dimerization | 1 | 2016 | 143 | 0.140 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2019 | 7 | 0.140 |
Why?
|
| Glucose | 1 | 2019 | 629 | 0.130 |
Why?
|
| Photochemical Processes | 1 | 2015 | 16 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2016 | 264 | 0.120 |
Why?
|
| Aminoquinolines | 1 | 2014 | 17 | 0.120 |
Why?
|
| Coculture Techniques | 1 | 2015 | 176 | 0.120 |
Why?
|
| Protein Structure, Quaternary | 1 | 2014 | 101 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2015 | 195 | 0.120 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2014 | 14 | 0.110 |
Why?
|
| Tin Compounds | 1 | 2013 | 2 | 0.110 |
Why?
|
| Volatilization | 1 | 2013 | 6 | 0.110 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2014 | 30 | 0.110 |
Why?
|
| Cell Movement | 1 | 2017 | 787 | 0.110 |
Why?
|
| Oxalates | 1 | 2013 | 49 | 0.110 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2013 | 46 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 262 | 0.110 |
Why?
|
| RNA | 1 | 2017 | 583 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2014 | 178 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2014 | 3404 | 0.110 |
Why?
|
| Ethanolamine | 1 | 2012 | 2 | 0.100 |
Why?
|
| Adsorption | 1 | 2012 | 53 | 0.100 |
Why?
|
| Fibroblasts | 1 | 2015 | 759 | 0.100 |
Why?
|
| Surface Properties | 1 | 2011 | 131 | 0.090 |
Why?
|
| Particle Size | 1 | 2011 | 126 | 0.090 |
Why?
|
| Pyridoxal Phosphate | 1 | 2010 | 12 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 1130 | 0.090 |
Why?
|
| Drug Design | 2 | 2023 | 126 | 0.090 |
Why?
|
| Immunity | 2 | 2023 | 141 | 0.090 |
Why?
|
| Immunogenicity, Vaccine | 2 | 2021 | 13 | 0.090 |
Why?
|
| Peptide Library | 1 | 2010 | 84 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 603 | 0.080 |
Why?
|
| Chemistry Techniques, Synthetic | 2 | 2019 | 9 | 0.080 |
Why?
|
| Female | 5 | 2024 | 46617 | 0.080 |
Why?
|
| Inteins | 1 | 2008 | 3 | 0.080 |
Why?
|
| Mesna | 1 | 2008 | 9 | 0.080 |
Why?
|
| Chitin | 1 | 2008 | 10 | 0.080 |
Why?
|
| Models, Biological | 1 | 2015 | 1766 | 0.080 |
Why?
|
| Amines | 1 | 2008 | 28 | 0.070 |
Why?
|
| Chromatography, Affinity | 1 | 2008 | 81 | 0.070 |
Why?
|
| Acrylamides | 1 | 2008 | 34 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 2588 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 309 | 0.070 |
Why?
|
| Angiotensin I | 1 | 2006 | 7 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2006 | 59 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 360 | 0.060 |
Why?
|
| Protein Engineering | 1 | 2006 | 145 | 0.060 |
Why?
|
| Bacterial Load | 1 | 2024 | 19 | 0.060 |
Why?
|
| Nucleotides, Cyclic | 1 | 2024 | 12 | 0.060 |
Why?
|
| Dinucleoside Phosphates | 1 | 2024 | 12 | 0.060 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2024 | 81 | 0.060 |
Why?
|
| Immunization | 1 | 2024 | 163 | 0.060 |
Why?
|
| Endopeptidases | 1 | 2024 | 118 | 0.060 |
Why?
|
| Cross-Priming | 1 | 2023 | 49 | 0.060 |
Why?
|
| Vagina | 1 | 2024 | 177 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2395 | 0.050 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2022 | 5 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2022 | 19 | 0.050 |
Why?
|
| Phase Transition | 1 | 2021 | 18 | 0.050 |
Why?
|
| Wood | 1 | 2021 | 19 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2021 | 172 | 0.050 |
Why?
|
| Histocompatibility | 1 | 2021 | 65 | 0.050 |
Why?
|
| Cellulose | 1 | 2021 | 58 | 0.040 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 311 | 0.040 |
Why?
|
| Antigens, Bacterial | 1 | 2021 | 136 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 469 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 1008 | 0.040 |
Why?
|
| Transition Temperature | 1 | 2017 | 11 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 417 | 0.040 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2017 | 26 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2017 | 123 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1292 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2015 | 82 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 2064 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 901 | 0.030 |
Why?
|
| Catalysis | 1 | 2011 | 205 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 117 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 283 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2010 | 211 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 895 | 0.020 |
Why?
|
| Cyclization | 1 | 2006 | 11 | 0.020 |
Why?
|
| Pyruvates | 1 | 2006 | 11 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 78 | 0.020 |
Why?
|
| Biomimetics | 1 | 2006 | 31 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3024 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2006 | 179 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 388 | 0.020 |
Why?
|
| Male | 1 | 2015 | 42705 | 0.010 |
Why?
|